Holdings
Alger Health Sciences Fund
As of Jul 31, 2026, Alger Health Sciences Fund reported 51 positions worth US$65.8M. Largest: Merck & Company, Inc., Welltower Inc. and Johnson & Johnson. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Merck & Company, Inc. | 24,176 | US$3.15M | +8,096 | Jul 31, 2026 |
| Welltower Inc. | 13,242 | US$3.1M | +4,210 | Jul 31, 2026 |
| Johnson & Johnson | 11,933 | US$3.06M | +4,017 | Jul 31, 2026 |
| Thermo Fisher Scientific Inc | 5,248 | US$3.01M | new | Jul 31, 2026 |
| Bruker Corporation | 47,717 | US$3M | new | Jul 31, 2026 |
| Illumina, Inc. | 14,514 | US$2.98M | new | Jul 31, 2026 |
| Cvs Health Corporation | 26,479 | US$2.77M | +10,027 | Jul 31, 2026 |
| Unitedhealth Group Incorporated | 6,561 | US$2.72M | +4,614 | Jul 31, 2026 |
| Teva Pharmaceutical Industries Limited | 76,047 | US$2.66M | −3,477 | Jul 31, 2026 |
| Eli Lilly And Company | 2,155 | US$2.48M | +1,471 | Jul 31, 2026 |